Leadership Overview
United Therapeutics has 5 executives leading key functions including finance, information technology, medical affairs, people operations, and lung biotechnology.
Driven by innovation in biotechnology, United Therapeutics is dedicated to developing transformative treatments for life-threatening conditions, focusing on unmet medical needs and improving patient outcomes through advanced scientific research and development.
Driven by innovation in biotechnology, United Therapeutics is dedicated to developing transformative treatments for life-threatening conditions, focusing on unmet medical needs and improving patient outcomes through advanced scientific research and development.
Leadership Roles at United Therapeutics
Harsh Hurkat - Senior Analyst - Chief Financial Officer Org
Harsh Hurkat, the Senior Analyst - Chief Financial Officer Org at United Therapeutics, directs financial analysis and strategic planning. This role involves detailed examination of financial data to support executive decision-making, ensuring fiscal responsibility across all organizational units. Hurkat's responsibilities include forecasting financial performance, managing budgets, and identifying opportunities for cost optimization and revenue enhancement. The position requires a deep understanding of financial markets and corporate finance principles to guide the company's financial health. By providing critical insights into financial trends and risks, Harsh Hurkat supports the executive team in navigating complex economic landscapes and achieving long-term financial stability. This leadership function is essential for maintaining the company's operational efficiency and its capacity for continued investment in research and development.
Jeffrey Kase - Vice President, Chief Information Officer
Jeffrey Kase, the Vice President, Chief Information Officer at United Therapeutics, architects and executes the company's comprehensive information technology strategy. This leadership position oversees all aspects of the IT infrastructure, including cybersecurity, data management, and digital transformation initiatives. Kase ensures that technology systems effectively support United Therapeutics' research, development, and operational goals, driving innovation and efficiency. The role involves managing a global IT team, implementing advanced technological solutions, and safeguarding sensitive company and patient data. By aligning IT capabilities with business objectives, Jeffrey Kase enhances operational agility and supports the company's mission to develop life-saving therapies. This critical function ensures robust technological support for all business units, facilitating seamless collaboration and data integrity across the organization.
Gil Golden - Chief Medical Officer
Gil Golden, the Chief Medical Officer at United Therapeutics, directs the company's clinical development strategy and medical affairs. This pivotal role involves overseeing all clinical trials, ensuring adherence to regulatory standards, and interpreting trial data to guide therapeutic development. Golden's expertise is crucial in translating scientific discoveries into viable medical treatments for patients with serious conditions. The position requires extensive medical knowledge and leadership in managing cross-functional teams, including research, regulatory affairs, and clinical operations. By championing patient safety and efficacy, Gil Golden ensures that United Therapeutics' pipeline products meet rigorous medical and ethical benchmarks. This leadership function is fundamental to advancing the company's mission of delivering innovative therapies to those in need.
Marc Lorber - Senior Vice President and Chief Medical Officer, Lung Biotechnology, PBC
Marc Lorber, the Senior Vice President and Chief Medical Officer, Lung Biotechnology, PBC at United Therapeutics, spearheads the medical strategy for the company's lung biotechnology initiatives. This executive leadership role focuses on advancing novel treatments for pulmonary diseases, guiding clinical research and development from early-stage investigation through regulatory approval. Lorber's responsibilities include overseeing the design and execution of clinical trials, ensuring the highest standards of patient care and data integrity. The position demands deep scientific acumen and strategic vision to navigate the complexities of developing advanced therapies for lung conditions. By driving medical innovation, Marc Lorber significantly contributes to United Therapeutics' commitment to addressing critical unmet medical needs in respiratory health. This specialized leadership function is vital for the success of the lung biotechnology portfolio.
Alyssa Friedrich - Executive Vice President & Chief People Officer
Alyssa Friedrich, the Executive Vice President & Chief People Officer at United Therapeutics, directs the company's human capital strategy and organizational development. This executive function encompasses talent acquisition, employee engagement, compensation and benefits, and fostering a positive and productive work environment. Friedrich is responsible for aligning people strategies with United Therapeutics' overarching business objectives, ensuring the company attracts, retains, and develops top talent. The role involves cultivating a culture of innovation, collaboration, and continuous learning across all departments. By prioritizing employee well-being and professional growth, Alyssa Friedrich strengthens the organization's capacity to achieve its mission of developing life-saving therapies. This leadership position is fundamental to building and sustaining a high-performing workforce.
Explore Leadership Teams in Manufacturing
Bayer is a global enterprise in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. They have divisions in pharmaceuticals, crop science, animal health, and consumer health. Bayer is headquartered in Leverkusen, Germany.
Company Leadership LS
JL
BC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership GA
ZP
AH
DL
Founded in 195 and headquartered in Paris, France, Pierre Fabre is a private pharmaceuticals and dermo-cosmetics company. The company is structured around two divisions: Pharmaceuticals (prescription drugs, consumer health care) and Dermo-cosmetics (including the Europe and Asia market-leader brand Eau Thermale Avène).
Company Leadership Ad
JL
OV
Founded in 1958 and headquartered in Chatswood, Australia, iNova Pharmaceuticals is an international organization that develops, markets, and sells a wide-range of prescription medicines and non-prescription consumer health products across Asia, Australia and New Zealand, and Africa.
Company Leadership
PS
SE
OM
Frequently Asked Questions Regarding United Therapeutics Top Executives and Leadership Team
